Digital marketing firm Crowd Media (ASX: CM8) has secured a prized contract to market and distribute London-based KINN Living’s eco-friendly home cleaning, sanitiser and laundry productions across Europe. The 3-year exclusive agreement will provide KINN with access to Crowd Media’s significant social media, digital influences and conversational commerce network to drive internet sales of KINN’s
Read More
Mental health medtech company Medibio (ASX: MEB) has continued its accelerated plans towards FDA approvals under new management with the company having lodged an FDA application overnight for their mental health screening software – MEBsleep. Having collected the required clinical data MEBsleep (previously named STAGER) tested more than 1,000 individuals using Medibio’s sleep staging algorithm
Read More
Education tech company KNeoMedia (ASX: KNM) is set to increase its global reach to the 1.5 million schools in India via an exclusive licensing agreement with Indian-based firm Augustya. The agreement will give Augustya exclusive rights to market and sell KneoWorld technology in India with KNeoMedia to receive approximately $40 for each seat licence sold.
Read More
Employment tech company LiveHire (ASX: LVH) has made a significant foray into the North American market having won the prized contract from Ian Martin Group which will implement the LiveHire human resources platform in the United States and Canada. The Direct Sourcing contract is expected to deliver LiveHire $1.2 million over 3 years with an
Read More
Having endured a rocky road over the past 12 months where their major project was rejected by the regulatory board three times, property developer Mustera Property Group (ASX: MPX) is finally set to get their Forbes project underway having received approval from the Joint Development Assessment Panel (JDAP). The $65m ‘Forbes Residences’ project located in
Read More
Australian fintech company Novatti Group (ASX: NOV) has reported a 67% rise in revenues from their payments processing business, a record for the company which has seen heightened activity amidst coronavirus lockdowns as businesses turn to digital payment solutions. For the quarter ending 31 March 2020, Novatti’s $1.72 million (unaudited) in payment processing revenue represented
Read More
Cannabinoid company Botanix Pharmaceuticals (ASX: BOT) has found its way into the fast lane towards FDA approval for their antimicrobial product BTX 1801, developed to prevent post-surgical infections, having secured Qualified Infectious Disease Product (QIPD) designation which will expedite their FDA review process. The designation of QIPD status for BTC 1801 is the first for
Read More
Shares in the lightly traded gloves manufacturer VIP Gloves (ASX: VIP) have skyrocketed this morning on news that the Company has such a large backlog of orders that their 24/7 production capacity is fully committed until December 2020. With their production facilities based in Malaysia and not impacted by the Malaysian Government’s COVID-19 biosecurity measures,
Read More
3D printing medtech company Osteopore (ASX: OSX) is set to continue their successful streak, following news that the company has received Australian Therapeutics Goods Administration (TGA) approval for three craniofacial products, after being placed into a trading halt Friday afternoon. The Osteomesh, Osteoplug, and Osteoplug-C, are used primarily to fill voids in a patient’s bone,
Read More
